|
Akumin Inc
AKU's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Akumin Inc 's sales fell
by -3.21 % in III. Quarter 2023 from the same quarter a year ago.
Ranking at No. 2366
Medical Laboratories industry recorded
growth of revenues by 4.32 %
Akumin Inc net loss increased from $-50 millions, to $-83 millions in III. Quarter 2023,
• More on AKU's Growth
|
|
Akumin Inc realized a net loss in trailing twelve months.
Akumin Inc realized cash reduction of $ -0.3 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
-0 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.04.
Medical Laboratories industry's Price to Sales ratio is at 2.52.
• More on AKU's Valuation
|
|
|
|
|
Akumin Inc realized net loss in trailing twelve months.
Akumin Inc realized cash outflow of $ -0.3per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
-0 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.04.
Medical Laboratories industry's Price to Sales ratio is at 2.52.
• More on AKU's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com